301212.SZ
联盛化学
SZSE · C 制造业 · CN
CNY 23.79
−4.34%Year over year
Reported trailing growth
- Revenue
- +4.2%
- EBITDA
- —
- EBIT
- -43.5%
- EPS
- -51.8%
- Free cash flow
- +74.1%
- Operating cash flow
- +174.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -12.7%
- EBITDA
- -37.7%
- EBIT
- -56.9%
- Net income
- -57.7%
- EPS
- -58.7%
- Free cash flow
- +86.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026